UroGen Pharma Ltd. - Ordinary Shares (URGN): Price and Financial Metrics
URGN Price/Volume Stats
Current price | $13.58 | 52-week high | $18.15 |
Prev. close | $12.96 | 52-week low | $3.42 |
Day low | $12.89 | Volume | 737,400 |
Day high | $13.62 | Avg. volume | 1,647,990 |
50-day MA | $9.63 | Dividend yield | N/A |
200-day MA | $10.92 | Market Cap | 626.13M |
URGN Stock Price Chart Interactive Chart >
UroGen Pharma Ltd. - Ordinary Shares (URGN) Company Bio
UroGen Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing therapies for urological pathologies. The company is developing its product candidates as chemoablation agents, which are designed to remove tumors by non-surgical means, to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial carcinoma, and low-grade bladder cancer. The company was founded in 2004 and is based in Raanana, Israel.
URGN Price Returns
1-mo | 176.02% |
3-mo | 32.49% |
6-mo | 21.14% |
1-year | N/A |
3-year | 66.63% |
5-year | N/A |
YTD | 27.51% |
2024 | -29.00% |
2023 | 69.11% |
2022 | -6.73% |
2021 | -47.23% |
2020 | -46.00% |
Loading social stream, please wait...